Loading…
Loading…
RGBOQ (ReGen Biologics Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
RGBOQ does not currently pay a dividend.
See exactly how RGBOQ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RGBOQ and 80,000+ other tickers.
ReGen Biologics Inc., established in 1987 and headquartered in Hackensack, New Jersey, specialized in the development, manufacturing, and commercialization of medical devices. These devices were engineered for the restoration and growth of soft human tissues, particularly within orthopedic fields. The company's core asset was its unique collagen matrix technology, which found broader utility across various medical disciplines including general surgery, spinal care, cardiovascular applications, and drug delivery. Key product offerings included the Menaflex collagen meniscus implant, designed…
No recent news available.